Primo 100
Methenolone Enanthate
Methenolone enanthate is a DHT-derived injectable that does not aromatize. 100 mg/ml × 10 ml; label 300–800 mg/week; half-life 5–7 days. Research notes describe milder androgenicity and lean, low-bloat appearance. Acne is listed yes; hepatotoxicity low. Presented for laboratory research documentation only. Not for human consumption.
Quality Control
Identity, strength, and pack size on this listing follow the supplied product photography. Batch-specific laboratory documentation can be requested through the contact form. For laboratory research documentation only. Not for human consumption, diagnostic, or therapeutic use.
Research Background
Methenolone enanthate is a DHT-derived injectable that does not aromatize. 100 mg/ml × 10 ml; label 300–800 mg/week; half-life 5–7 days. Research notes describe milder androgenicity and lean, low-bloat appearance. Acne is listed yes; hepatotoxicity low. Presented for laboratory research documentation only. Not for human consumption.
Handling & Storage
Store at 20–25°C (room temperature). Protect from direct sunlight and freezing. Restricted laboratory access — keep out of reach of children and unauthorized users.
Quality Assurance
innov8pharma presents this material for laboratory documentation. Certificate of Analysis files can be requested per batch. Not for human consumption.
| Compound | Methenolone enanthate (Primobolan) |
|---|---|
| Form | Intramuscular oil (multiuse vial) |
| Pack | 10 ml vial · 100 mg/ml |
| Label dosage range | 300–800 mg/week |
| Water Retention | Low |
| Aromatization | No |
| Half Life | 5–7 days |
| HBR | Perhaps |
| Acne | Yes |
| Hepatotoxicity | Low |
| Storage | 20–25°C |
